Nolan Mangini Siobhan
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
1679464
1679464
EIN:
SIC:
(CF Office: )
State location:
State of
incorporation:
Fiscal year end:
Business address:
Phone:
Phone:
Mailing address:
C/O NMG BIOPHARMACEUTICALS, INC., 333 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
C/O NMG BIOPHARMACEUTICALS, INC., 333 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Category:
Filings:
44 EDGAR filings since July 12, 2016
44 EDGAR filings since July 12, 2016
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
No Filings for this company
Selected Filings
[+] 8-K (current reports)
No 8-K filing data for this company in last 110 days
[+] 10-K (annual reports) and 10-Q (quarterly reports)
No 10-K/10-Q filings for this company in last 365
days
[+] Proxy (annual meeting) and information statements
No Proxy filings for this company in last 365 days
[+] Ownership disclosures
- Insider transactions
- January 17, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
No beneficial ownership filings for this company in last 365 days
Filings
Form type | Form description | Filing date | Reporting date |
---|
0
Showing 1 to 44 of 44 entries
Data source:
CIK0001679464.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors